Eagle Health Investments LP: GUARDANT HEALTH INC (GH): Quarterly 13F Position History
As of Q1 2026, Eagle Health Investments LP reported 310,281 shares of GUARDANT HEALTH INC (GH), worth $28.7M and representing 6.0% of its 13F equity book. Quarter-over-quarter share count change: + 26,181 (+9.2%) . The position first appeared in Q4 2020 and has been disclosed across 22 13F-HR filings in Pactolio's tracked window.
- 310,281Shares Held (Latest Filing)
- $28.7MReported Market Value (Latest Filing)
- 6.0%Portfolio Weight (% of 13F Equity Book)
- +26,181Quarter-over-Quarter Share Change
- -$357.3KQuarter-over-Quarter Value Change
- 730,209Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 22 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 310,281 | +26,181 | +9.2% | $28.7M | 6.0% | $92.4 |
| Q4 2025 | 284,100 | 0 | — | $29.0M | 6.4% | $102.1 |
| Q3 2025 | 284,100 | +72,100 | +34.0% | $17.8M | 4.7% | $62.5 |
| Q2 2025 | 212,000 | +212,000 | — | $11.0M | 2.7% | $52.0 |
| Q1 2025 | 0 | 0 | — | $0 | 0.0% | — |
| Q4 2024 | 0 | 0 | — | $0 | 0.0% | — |
| Q3 2024 | 0 | 626,909 | -100.0% | $0 | 0.0% | — |
| Q2 2024 | 626,909 | 103,300 | -14.1% | $18.1M | 3.2% | $28.9 |
| Q1 2024 | 730,209 | +610,100 | +508.0% | $15.1M | 2.9% | $20.6 |
| Q4 2023 | 120,109 | 84,752 | -41.4% | $3.2M | 0.7% | $27.1 |
| Q3 2023 | 204,861 | 240,300 | -54.0% | $6.1M | 1.3% | $29.6 |
| Q2 2023 | 445,161 | 151,400 | -25.4% | $15.9M | 3.0% | $35.8 |
| Q1 2023 | 596,561 | +530,001 | +796.3% | $14.0M | 2.7% | $23.4 |
| Q4 2022 | 66,560 | 85,400 | -56.2% | $1.8M | 0.4% | $27.2 |
| Q3 2022 | 151,960 | 0 | — | $8.2M | 1.9% | $53.8 |
| Q2 2022 | 151,960 | 0 | — | $6.1M | 1.4% | $40.3 |
| Q1 2022 | 151,960 | +32,600 | +27.3% | $10.1M | 2.5% | $66.2 |
| Q4 2021 | 119,360 | +23,700 | +24.8% | $11.9M | 2.9% | $100.0 |
| Q3 2021 | 95,660 | +67,400 | +238.5% | $12.0M | 3.8% | $125.0 |
| Q2 2021 | 28,260 | 0 | — | $3.5M | 1.2% | $124.2 |
| Q1 2021 | 28,260 | 4,200 | -12.9% | $4.3M | 1.8% | $152.7 |
| Q4 2020 | 32,460 | — | — | $4.2M | 2.7% | $128.9 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Eagle Health Investments LP first disclose a GH position in 13F-HR filings?
Eagle Health Investments LP first reported GUARDANT HEALTH INC (GH) on its 13F-HR filing for the period ending 2020-12-31 (Q4 2020). The position has appeared on 22 reported quarters within Pactolio's tracked window.
What was Eagle Health Investments LP's most recent quarter-over-quarter share-count change in GH?
Between Q4 2025 and Q1 2026, Eagle Health Investments LP added 26,181 shares of GH (+9.2%), bringing the total reported position to 310,281 shares at a market value of $28.7M.
Does the implied price-per-share represent Eagle Health Investments LP's cost basis in GH?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.